Skip to main content
. 2018 Mar 8;6(1):14. doi: 10.3390/vaccines6010014

Figure 2.

Figure 2

GMT increase, seroconversion or significant increase % and seroprotection % induced by Vaxigrip Tetra in subjects aged 18–60 years and >60 years. Vaxigrip Tetra met EMA criteria in both age groups (as indicated by the dotted thick black line) [83].